Drug delivery to the ear

Therapeutic Delivery

Volumn 4, Issue 1, 2013, Pages 115-124

  Hoskison, E ^a,b   Daniel, M ^a,b,c   Al Zahid, S ^a,c   Shakesheff, K M ^c   Bayston, R ^a,c   Birchall, J P ^a,b  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b NIHR Nottingham Hearing Biomedical Research Unit   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMINOGLYCOSIDE DERIVATIVE; AMOXICILLIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BENDROFLUMETHIAZIDE; BETNOVATE N; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLOBETASONE BUTYRATE; DEXAMETHASONE; GACYCLIDINE; GENTAMICIN; GENTISONE; INFLIXIMAB; LIDOCAINE; LOCAL ANESTHETIC AGENT; MACROGOL; METRONIDAZOLE; NANOCAPSULE; NEUROPROTECTIVE AGENT; PIPERACILLIN; POLOXAMER; POLYGLACTIN; POLYLACTIC ACID; POLYMER; PREDNISOLONE; SOFRADEX; STEROID; SURFACTANT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACUTE OTITIS MEDIA; ANATOMY; AUDITORY TUBE; AUTOIMMUNE DISEASE; CATHETER; CHRONIC SUPPURATIVE OTITIS MEDIA; DRUG BIOAVAILABILITY; DRUG DELIVERY DEVICE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG SAFETY; DRUG SELF ADMINISTRATION; DRUG TISSUE LEVEL; DRUG TOLERABILITY; EAR DISEASE; EARDRUM; EXTERNAL OTITIS; HEARING IMPAIRMENT; HUMAN; HYPERGLYCEMIA; HYPOKALEMIA; INCISION; INNER EAR DISEASE; MENIERE DISEASE; MENTAL DISEASE; NANOMEDICINE; NEPHROTOXICITY; NONHUMAN; ORTHOSTATIC HYPOTENSION; OTITIS MEDIA; OTOTOXICITY; PANCREATITIS; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; REVIEW; STOMACH HEMORRHAGE; STOMACH ULCER; TINNITUS; TISSUE FLAP; TYMPANOMEATAL FLAP; VESTIBULAR DISORDER;

EID: 84871553055     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.12.130     Document Type: Review

References (64)

1. Scott-Brown's Otorhinolaryngology. In: Head and Neck Surgery (Seventh Edition). Gleeson M (Ed. ). Hodder Arnold Ltd, London, UK (2008).
2. Nakagawa T, Ito J. Local drug delivery to the inner ears using biodegradeable materials. Ther. Deliv. 2, 807-814 (2011).
3. Goycoolea MV, Lundman L. Round window membrane structure function and permeability: a review. Microsc. Res. Tech. 36, 201-211(1997).
4. Ishii T, Toriyama M, Suzuki JI. Histopathological study of otitis media with effusion. Ann. Otol. Rhinol. Laryngol. Suppl. 89, 83-86 (1980).
5. Tos M. Pathogenesis and pathology of chronic secretory otits media. Ann. Otol. Rhinol. Laryngol. Suppl. 89, 91-97 (1980).
6. Scottish intercollegiate guidelines network. Diagnosis and Management of Childhood Otitis Media in Primary Care. Scottish intercollegiate guidelines network, Edinburgh, UK, 66 (2006).
7. Celin SE, Bluestone CD, Stephenson J, Yimaz HM, Collins JJ. Bacteriology of acute Otitis media in adults. JAMA 266, 2249-2252 (1991).
8. Thornsberry C, Sahm DF, Kelly LJ et al. Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumonia, Haemophilus influenza and Moraxella catarrhalis in the United States: results from the TRUST surveillance program 1999-2000. Clin. Infect. Dis. 34, S4-S16 (2002).
9. Woodford N, Livermore DM. Infections caused by Gram-positive bacteria: a review of the global challenge. J. Infect. 59(Suppl. 1), S4-S16 (2009).
10. Pichichero ME, Reed MD. Variations in amoxicillin pharmacokinetic/ pharmacodynamic parameters may explain treatment failures in acute otitis media. Paediatr. Drugs 11, 243-249 (2009).
11. Mandel EM, Doyle WJ, Winther B, Alper CM. The incidence, prevalence and burden of OM in unselected children aged 1-8 years followed by weekly otoscopy through the 'common cold' season. Int. J. Pediatr. Otorhinolaryngol. 72, 491-499 (2008).
12. Hall-Stoodley L, Hu FZ, Gieseke A et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 296, 202-211(2006).
13. Fergie N, Bayston R, Pearson JP, Birchall JP. Is otitis media with effusion a biofilm infection? Clin. Otolaryngol. Allied Sci. 29, 38-46 (2004).
14. Kubba H, Pearson JP, Birchall JP. The aetiology of otitis media with effusion: a review. Clin. Otolaryngol. 25, 181-194 (2000).
15. Post JC. Direct evidence of bacterial biofilms in otitis media. Laryngoscope 111, 2083-2094 (2001).
16. Daniel M, Rahman C, Ashraf W et al. Development of an in-vitro model of Staphylococcus aureus biofilm infection with a focus on reduced susceptibility to antibiotics. J. Hosp. Infect. 76, S4-S5 (2010).
17. Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch. Otolaryngol. 106, 772-776 (1980).
18. Jackson CG, Glasscock ME 3rd, Davis WE, Hughes GB, Sismanis A. Medical management of Menière's disease. Ann. Otol. Rhinol. Laryngol. 90, 142-147 (1981).
19. Santos PM, Hall RA, Snyder JM, Hughes LF, Dobie RA. Diuretic and diet effect on Menière's disease evaluated by the 1985 Committee on Hearing and Equilibrium guidelines. Otolaryngol. Head Neck Surg. 109, 680-689 (1993).
20. Lin CY, Wu JL, Shih TS et al. N-acetyl cysteine against noise induced temporary threshold shift in male workers. Hear. Res. 269, 42-47 (2010).
21. Huth ME, Ricci AJ, Cheng AG. Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection. Int. J. Otolaryngol. 937861 (2011).
22. Greenwood GJ. Neomycin ototoxicity; report of a case. A. M. A. Arch. Otolaryngol. 69, 390-397 (1959).
23. Fee WE. Aminoglycoside ototoxicity in the human. Laryngoscope 90, 1-19 (1980).
24. Mulheran M, Degg C, Burr S, Morgan DW, Stableforth DE. Occurrence and risk of cochleotoxicity in cystic fibrosis patients receiving repeated high-dose aminoglycoside therapy. Antimicrob. Agents Chemotherap. 45, 2502-2509 (2001).
25. Imaimura S, Adams JC. Distribution of gentamicin in the guinea pig inner ear after local or systemic application. J. Assoc. Res. Otolaryngol. 4, 176-195 (2003).
26. Kakehata S, Sasaki A, Oji K et al. Comparison of intratympanic and intravenous dexamethasone treatment on sudden sensorineural hearing loss with diabetes. Otol. Neurotol. 27, 604-608 (2006).
27. Shea PF, Richey PA, Wan JY, Stevens SR. Hearing results and quality of life after streptomycin/dexamethasone perfusion for Ménière's disease. Laryngoscope 122, 204-211(2012).
28. Horie R, Sakamoto T, Nagakawa T et al. Stealth annoparticle strategy for enhancing the efficacy of steroids in mice with noise-induced hearing loss. Nanomedicine 5, 1331-1340 (2010).
29. Passàli D, Bellussi L, Masieri S. Transtympanic iontophoresis: personal experience. Laryngoscope 94, 802-806 (1984).
30. Shapiro B, Dormer K, Rutel IB. A two-magnet system to push therapeutic nanoparticles. AIP Conf. Proc. 1311, 77-88 (2010).
31. Chandrasekhar SS. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol. Neurotol. 22, 18-23(2001).
32. Ho HG, Lin HC, Shu MT, Yang CC, Tsai HT. Effectiveness of intratympanic dexamethasone injection in sudden-deafness patients as salvage treatment. Laryngoscope 114, 1184-1189 (2004).
33. Shulman A, Goldstein B. Intratympanic drug therapy with steroids for tinnitus control: a preliminary report. Int. Tinnitus J. 6, 10-20 (2000).
34. Jackson LE, Silverstein H. Chemical perfusion of the inner ear. Otolaryngol. Clin. North Am. 35, 639-653 (2002).
35. Berryhill WE, Graham MD. Chemical and physical labyrinthectomy for Ménière's disease. Otolaryngol. Clin. North Am. 35, 675-682 (2002).
36. Yoshioka M, Naganawa S, Sone M, Nakata S, Teranishi M, Nakashima T. Individual differences in the permeability of the round window: evaluating the movement of intratympanic gadolinium into the inner ear. Otol. Neurotol. 30, 645-648 (2009).
37. Chen Y, Wen L, Hu P, Qiu J, Lu L, Qiao L. Endoscopic intratympanic methylprednisolone injection for treatment of refractory sudden sensorineural hearing loss and one case in pregnancy. J. Otolaryngol. Head Neck Surg. 39, 640-645 (2010).
38. Cesarani A, Capobianco S, Soi D, Giuliano DA, Alpini D. Intratympanic dexamethasone treatment for control of subjective idiopathic tinnitus: our clinical experience. Int. Tinnitus J. 8, 111-114 (2002).
39. Fu Y, Zhao H, Zhang T, Chi F. Intratympanic dexamethasone as initial therapy for idiopathic sudden sensorineural hearing loss: clinical evaluation and laboratory investigations. Auris Nasus Larynx. 38, 165-171 (2011).
40. Rauch SD, Halpin CF, Antonelli PJ et al. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. JAMA 305, 2071-2079 (2011).
41. Salt AN, King EB, Hartstock JJ, Gill RM, O'Leary SJ. Marker entry into vestibular perilymph via the stapes following application to the round window niche of guinea pigs. Hear. Res. 283, 14-23 (2012).
42. Mikulec AA, Hartstock JJ, Salt AN. Permeability of the round window membrane is influenced by the composition of applied drug solutions and by common surgical procedures. Otol. Neurotol. 29, 1020-1026 (2008).
43. Wenzel GI, Warnecke A, Stöver T, Lenarz T. Effects of extracochlear gacyclidine perfusion on tinnitus in humans: a case series. Eur. Arch. Otorhinolaryngol. 267, 691-699 (2010).
44. Plontke SK, Löwenheim H, Mertens J et al. Randomized, double blind placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Laryngoscope 119, 359-369 (2009).
45. Plontke SK, Zimmermann R, Zenner HP, Löwenheim H. Technical note on microcatheter implantation for local inner ear drug delivery: surgical technique and safety aspects. Otol. Neurotol. 27, 912-917 (2006).
46. Light JP, Silverstein H. Transtympanic perfusion: indications and limitations. Curr. Opin. Otolaryngol. Head Neck Surg. 12, 378-383(2004).
47. Suryanarayanan R, Srinivasan VR, O'Sullivan G. Transtympanic gentamicin treatment using Silverstein MicroWick in Ménière's disease. J. Laryngol. Otol. 123, 45-49 (2009).
48. Hill SL 3rd, Digges EN, Silverstein H. Long term follow-up after gentamicin application via Silverstein MicroWick in the treatment of Ménière's disease. Ear Nose Throat J. 85, 494, 496, 498 (2006).
49. Van Wijk F, Steacker H, Lefebvre PP. Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment. Acta Otolaryngol. 127, 1012-1017 (2007).
50. Van Wijck F, Staecker H, Keithley E, Lefebvre PP. Local perfusion of the tumour necrosis factor blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss. Audiol. Neurootol. 11, 357-365 (2006).
51. Al-Zahid S, Daniel M, Chessman R et al. The treatment of glue ear using biodegradable polymers to deliver high dose antibiotics and mucolytics to infection site. Int. J. Surg. 9, 496 (2011).
52. Piu F, Wang X, Fernandez R et al. OTO-104: a sustained-release dexamethasone hydrogel for the treatment of otic disorders. Otol. Neurotol. 32, 171-179 (2011).
53. Horie RT, Sakamoto T, Nakagawa T et al. Sustained delivery of lidocaine into the cochlea using poly lactic/glycolic acid microparticles. Laryngoscope 120, 377-383 (2010).
54. Zou J, Saulnier P, Perrier T et al. Distribution of lipid nanocapsules in different cochlear cell populations after round window membrane permeation. J. Biomed. Mater. Res. B Appl. Biomater. 87, 10-18 (2008).
55. Tamura T, Kita T, Nakagawa T et al. Drug delivery to the cochlea using PLGA nanoparticles. Laryngoscope 115, 2000-2005 (2005).
56. Cheper V, Wolf M, Scholl M et al. Potential novel drug carriers for inner ear treatment. Nanomedicine 4, 623-635 (2009).
57. McCall AA, Swan EE, Borenstein JT, Sewell WF, Kujawa SG, McKenna MJ. Drug delivery for treatment of inner ear disease: current state of knowledge. Ear Hear. 31, 156-165 (2010).
58. Gao X, Want Y, Chen K et al. Magnetic assisted transport of PLGA nanoparticles through a human round window membrane model. J. Nanotechnol. Engin. Med. 1(3), 031010 (2010).
59. Philpott C, Gane S, McKiernan D. Nanomedicine in otolaryngology: what does the future hold? Eur. Arch. Otolaryngol. 268, 489-496 (2011).
60. Karagama YG, Rashid M, Lancaster JL, Karkanevatos A, William RS. Intranasal delivery of drugs to the Eustachian tube orifice. J. Laryngol. Otol. 125, 934-939 (2011).
61. Chandrasekhar SS, Mautone AJ. Otitis media: treatment with intranasal aerosolized surfactant. Laryngoscope 114, 472-485 (2004).
62. Peters G, Lin J, Arriaga MA et al. Middle-ear endoscopy and trans-tympanic drug delivery using an interventional sialendoscope: feasibility study in human cadaveric temporal bones. J. Laryngol. Otol. 124, 1263-1267 (2010).
63. Praetorius M, Limberger A, Müller M et al. A novel microperfusion system for the long-term local supply of drugs to the inner ear: implantation and function in the rat model. Audiol. Neurootol. 6, 250-258 (2001).
64. Lehner R, Brugger H, Massen MM, Zenner HP. A totally implantable drug delivery system for local therapy of the middle and inner ear. Ear Nose Throat J. 76, 567-570 (1997).